ICR Reveals New Courses on EU Regulation & Line Management
ICR has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management.
The Institute of Clinical Research (ICR) has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management. The former event is scheduled for December 9, while the latter will take place on December10-11.
Other eye-catching training sessions being organized by ICR are on skills and competencies of a clinical trials manager (October 9-10), effective clinical trial management (November 11-13), and essentials of clinical trials monitoring (November 25).
ICR is a not-for-profit organization that provides education and training, conferences and networking events, and news updates and analysis on all aspects of clinical research. Members are engaged in all aspects of work in clinical research, both directly and in the support services. It was founded in 1978 as ACRPI (Association of Clinical Research for the Pharmaceutical Industry), and changed its name to ICR in 2000. Its head office is in Maidenhead, Berkshire, U.K., and it has over 3000 members in 49 countries around the world.
For further details, contact icrenquiries@yahoo.co.uk or visit http://www.icr-global.org/home/.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
